Breastfeeding Can Transfer COVID-19 Booster Antibodies to Babies
Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk and potentially protect babies too young to receive the vaccine.
Tag: antibodies
All
Latest
All
LatestNIH Launches Monoclonal Antibody Trial to Treat Asthma in Urban Youth
The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.
All
Latest
FDA: Two Monoclonal Antibody Treatments Ineffective Against Omicron Variant
The FDA has removed two monoclonal antibody therapies from its list of emergency authorized COVID-19 treatments due to their ineffectiveness against the Omicron variant.
Antibody Protects Against Variants
Researchers have identified an antibody that is highly protective at low doses against a wide range of COVID-19 variants.
Read More
Cytokine Levels Could Predict Asthma Patients’ Response to Benralizumab
Levels of inflammatory cytokines in patients with severe asthma may predict responses to the monoclonal antibody benralizumab, a study in the Journal of Asthma suggests.
Read More
Antibodies in Lungs Can Prevent Severe Respiratory Infections
Differences in lung-specific antibodies and antibody-secreting cells may be one of the important factors determining severe vs mild symptoms from respiratory infections.
Read More
FDA Authorizes Monoclonal Antibody Actemra for Hospitalized COVID-19 Patients
The US FDA issued an emergency use authorization for the monoclonal antibody Actemra (tocilizumab) for the treatment of hospitalized adults and pediatric patients age 2 and older.
Read More
Regen-Cov Reduced COVID-19 Hospital Mortality by 20% in Seronegative Patients
Regen-Cov (casirivimab and imdevimab) added to usual care reduced the risk of death by 20% in hospitalized patients who had not mounted a natural antibody response on their own against SARS-CoV-2.
Read More
FDA Okays Lower Dose of Regeneron Monoclonal Antibody Cocktail
Regeneron’s COVID-19 monoclonal antibody cocktail (casirivimab + imdevimab) is now authorized at half the dose for patients age 12 and older.
Read More
FDA Revokes EUA for Monoclonal Antibody Bamlanivimab
The US FDA has revoked an EUA for the monoclonal antibody bamlanivimab when administered alone, for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
Read More
Regeneron Monoclonal Antibodies Reduced COVID-19 Transmission Risk by 81%
Regen-CoV — a monoclonal antibody cocktail from Regeneron — reduced the risk of symptomatic SARS-CoV-2 infections by 81% in a Phase 3 clinical trial.
Read More
FDA Authorizes Symbiotica COVID-19 Self-Collected Antibody Test
The US FDA has issued an EUA for the Symbiotica COVID-19 Self-Collected Antibody Test System, the first antibody test authorized for use with home collected dried blood spot samples.
Read More
FDA to Review Expanded Application of Dupixent for Childhood Asthma
The FDA will review an sBLA for Dupixent (dupilumab) as an add-on treatment for children aged 6 to 11 years with uncontrolled moderate-to-severe asthma.
Read More
Monoclonal Antibodies Effective against MERS Coronavirus in First Human Trial
The first Phase 1 clinical trial of two monoclonal antibodies to treat Middle East respiratory syndrome coronavirus (MERS-CoV) found that they were well tolerated and generally safe when administered simultaneously to healthy adults.
Read More
Low Reinfection Risk for People with SARS-CoV-2 Antibodies
People who have had evidence of a prior infection with SARS-CoV-2 appear to be well protected against being reinfected with the virus, at least for a few months.
Read More